Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes.
We conducted a randomized controlled trial using mobile health technology in an ethnically diverse sample of 137 patients with complicated diabetes. Patients in the intervention group (n = 72) were trained to measure their blood glucose with a sensor which transmitted the readings to a mobile phone via a Bluetooth wireless link. Clinicians were then able to examine and respond to the readings which were viewed with a web-based application. Patients in the control arm of the study (n = 65) did not transmit their readings and received care with their usual doctor in the outpatient and/or primary care setting. The mean follow-up period was 9 months in each group. The default rate was higher in the patients in the intervention arm due to technical problems. In an intention-to-treat analysis there were no differences in HbA(1c) between the intervention and control groups. In a sub-group analysis of the patients who completed the study, the telemonitoring group had a lower HbA(1c) than those in the control group: 7.76% and 8.40%, respectively (P = 0.06).
Mobile Information and Network Technologies Centre, Kingston University, London, UK.
Robert S H
RS
Istepanian
Karima
K
Zitouni
Diane
D
Harry
Niva
N
Moutosammy
Ala
A
Sungoor
Bee
B
Tang
Kenneth A
KA
Earle
D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation / Q000379:methods*; D040421:Cell Phone / Q000295:instrumentation*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D017216:Telemedicine / Q000295:instrumentation* / Q000379:methods
D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human